PRM / LEO Pharma appoints new Chief Financial Officer and Executive Vice President

    Pressemeddelelse fra LEO Pharma

    Philip joins LEO Pharma from Topsoe where he has been CFO since November 2020. Previously, he was CFO at Atos Medical and before that held various leadership positions with Coloplast, including Regional CFO, North America & Pacific. Philip brings extensive experience across finance, strategy and M&A and has a proven track record of driving business transformation.

    Philip has a management consulting background from Bain & Company and attained his M.Sc. in Finance and Accounting from Copenhagen Business School and University of Michigan's Ross Business School.

    "I am confident that Philip will be a strong addition to the Global Leadership Team of LEO Pharma. He has an impressive track record as a global CFO from industry leading organizations and as a highly experienced strategic leader. I look very much forward to working closely with Philip as LEO Pharma goes through the next important steps of transformation," said Christophe Bourdon, CEO of LEO Pharma.

    "Joining LEO Pharma represents a unique opportunity for me to return to the healthcare industry. Also, I am excited about LEO Pharma's transformational journey ahead supported by the joint ownership of the LEO Foundation and Nordic Capital. I look forward to meeting all my new colleagues and working together to make a real difference for people living with skin conditions," said Philip Eickhoff.

    Philip succeeds Anders Kronborg, who joined LEO Pharma in 2015. Anders has served as CFO and as Interim CEO during his time at LEO Pharma. He will retire from the company to pursue opportunities as a professional board member and advisor. Anders shared his intent to retire with the Chair of the Board of Directors in the Autumn of 2021 to ensure a timely onboarding of a suitable successor who can support LEO Pharma in achieving its long-term ambitions.

    "I would like to thank Anders very much for his strong commitment to LEO Pharma over the years and his dedication to supporting the business in helping more people living with skin conditions. I wish him all the best of luck in his future endeavors", said Christophe Bourdon.

    Kontakt:

    Media Contact
    Henrik Heskjaer
    hdtdk@leo-pharma.com
    Director, Global External Communications
    Tel: +45 3140 6180

    Læs hele pressemeddelelsen på Via Ritzau her: https://via.ritzau.dk/pressemeddelelse/leo-pharma-appoints-new-chief-financial-officer-and-executive-vice-president?releaseId=13657055

    ** Ovenstående pressemeddelelse er videreformidlet af Ritzau på vegne af tredjepart. Ritzau er derfor ikke ansvarlig for indholdet **